HEADER ISOMERASE 25-AUG-02 1H3C TITLE STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO AN TITLE 2 HOMOLOGOUS ENZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: SQUALENE--HOPENE CYCLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: SHC; COMPND 5 EC: 5.4.99.17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ALICYCLOBACILLUS ACIDOCALDARIUS; SOURCE 3 ORGANISM_TAXID: 405212; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 6 EXPRESSION_SYSTEM_VARIANT: JM105; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PKK223-3; SOURCE 9 OTHER_DETAILS: THERMOSTABLE, ACIDOPHILIC KEYWDS ISOMERASE, CHOLESTEROL BIOSYNTHESIS, INHIBITOR, INTERACTIONS, KEYWDS 2 OXIDOSQUALENE CYCLASE, MONOTOPIC MEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR A.LENHART,D.J.REINERT,W.A.WEIHOFEN,J.D.AEBI,H.DEHMLOW,O.H.MORAND, AUTHOR 2 G.E.SCHULZ REVDAT 4 13-JUN-18 1H3C 1 TITLE REVDAT 3 20-NOV-13 1H3C 1 COMPND SOURCE REMARK VERSN REVDAT 3 2 1 FORMUL REVDAT 2 24-FEB-09 1H3C 1 VERSN REVDAT 1 21-AUG-03 1H3C 0 JRNL AUTH A.LENHART,D.J.REINERT,J.D.AEBI,H.DEHMLOW,O.H.MORAND, JRNL AUTH 2 G.E.SCHULZ JRNL TITL BINDING STRUCTURES AND POTENCIES OF OXIDOSQUALENE CYCLASE JRNL TITL 2 INHIBITORS WITH THE HOMOLOGOUS SQUALENE-HOPENE CYCLASE JRNL REF J.MED.CHEM. V. 46 2083 2003 JRNL REFN ISSN 0022-2623 JRNL PMID 12747780 JRNL DOI 10.1021/JM0211218 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.LENHART,W.A.WEIHOFEN,A.E.W.PLESCHKE,G.E.SCHULZ REMARK 1 TITL CRYSTAL STRUCTURE OF A SQUALENE CYCLASE IN COMPLEX WITH THE REMARK 1 TITL 2 POTENTIAL ANTICHOLESTEREMIC DRUG RO48-8071 REMARK 1 REF CHEM.BIOL. V. 9 639 2002 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 12031670 REMARK 1 DOI 10.1016/S1074-5521(02)00138-2 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.U.WENDT,A.LENHART,G.E.SCHULZ REMARK 1 TITL THE STRUCTURE OF THE MEMBRANE PROTEIN SQUALENE-HOPENE REMARK 1 TITL 2 CYCLASE AT 2.0 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 286 175 1999 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9931258 REMARK 1 DOI 10.1006/JMBI.1998.2470 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.U.WENDT,K.PORALLA,G.E.SCHULZ REMARK 1 TITL STRUCTURE AND FUNCTION OF A SQUALENE CYCLASE REMARK 1 REF SCIENCE V. 277 1811 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 9295270 REMARK 1 DOI 10.1126/SCIENCE.277.5333.1811 REMARK 1 REFERENCE 4 REMARK 1 AUTH O.H.MORAND,J.D.AEBI,H.DEHMLOW,Y.H.JI,N.GAINS,H.LENGSFELD, REMARK 1 AUTH 2 J.HIMBER REMARK 1 TITL RO48-8071, A NEW 2,3-OXIDOSQUALENE:LANOSTEROL CYCLASE REMARK 1 TITL 2 INHIBITOR LOWERING PLASMA CHOLESTEROL IN HAMSTERS, SQUIRREL REMARK 1 TITL 3 MONKEYS, AND MINIPIGS: COMPARISON TO SIMVASTATIN REMARK 1 REF J.LIPID RES. V. 38 373 1997 REMARK 1 REFN ISSN 0022-2275 REMARK 1 PMID 9162756 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 73.0 REMARK 3 NUMBER OF REFLECTIONS : 45709 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.258 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 14892 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 147 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : RESTRAINTS REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1H3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1290011313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 4.80 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200B REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49807 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 46.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 73.0 REMARK 200 DATA REDUNDANCY : 1.500 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.80 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 162.87133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.43567 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 81.43567 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 162.87133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 70.37750 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 121.89741 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 162.87133 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 140.75500 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 162.87133 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 211.13250 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 121.89741 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 162.87133 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES CYCLIZATION OF SQUALENE TO HOPENE. REMARK 400 KEY ENZYME IN HOPANOID (TRITERPENOID) METABOLISM. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 3 REMARK 465 GLN A 4 REMARK 465 LEU A 5 REMARK 465 VAL A 6 REMARK 465 GLU A 7 REMARK 465 ALA A 8 REMARK 465 PRO A 9 REMARK 465 ARG A 630 REMARK 465 ARG A 631 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLU B 3 REMARK 465 GLN B 4 REMARK 465 LEU B 5 REMARK 465 VAL B 6 REMARK 465 GLU B 7 REMARK 465 ALA B 8 REMARK 465 PRO B 9 REMARK 465 ARG B 630 REMARK 465 ARG B 631 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLU C 3 REMARK 465 GLN C 4 REMARK 465 LEU C 5 REMARK 465 VAL C 6 REMARK 465 GLU C 7 REMARK 465 ALA C 8 REMARK 465 PRO C 9 REMARK 465 ARG C 630 REMARK 465 ARG C 631 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 629 CA C O CB CG CD OE1 REMARK 470 GLU A 629 OE2 REMARK 470 GLU B 629 CA C O CB CG CD OE1 REMARK 470 GLU B 629 OE2 REMARK 470 GLU C 629 CA C O CB CG CD OE1 REMARK 470 GLU C 629 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 188 C - N - CA ANGL. DEV. = 9.1 DEGREES REMARK 500 PRO B 188 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO C 188 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 33 101.83 -161.89 REMARK 500 SER A 38 -118.14 -148.41 REMARK 500 ASP A 75 -9.54 -54.01 REMARK 500 ARG A 105 -15.35 -48.73 REMARK 500 GLU A 107 143.86 -38.09 REMARK 500 SER A 119 -4.35 -59.89 REMARK 500 ARG A 158 66.76 -109.30 REMARK 500 ILE A 163 -14.28 -45.56 REMARK 500 PHE A 187 78.21 -117.16 REMARK 500 PRO A 188 131.09 -38.67 REMARK 500 VAL A 195 58.91 -114.95 REMARK 500 GLU A 200 94.52 -54.29 REMARK 500 TRP A 216 -19.99 -46.31 REMARK 500 LEU A 231 170.66 -59.37 REMARK 500 PRO A 263 -80.49 -49.61 REMARK 500 LEU A 326 148.09 -36.90 REMARK 500 ASP A 392 75.32 -100.81 REMARK 500 CYS A 435 81.71 -66.05 REMARK 500 ASN A 492 -92.48 -155.22 REMARK 500 ILE A 509 151.90 -48.01 REMARK 500 GLU A 513 156.78 -43.07 REMARK 500 ASP A 530 11.07 -66.11 REMARK 500 ALA A 546 104.20 -57.44 REMARK 500 ARG A 568 25.62 -73.00 REMARK 500 GLU A 593 85.39 -160.54 REMARK 500 PRO A 594 3.29 -68.94 REMARK 500 ALA A 627 0.49 -61.24 REMARK 500 ILE A 628 -67.34 -133.21 REMARK 500 SER B 38 -116.96 -148.25 REMARK 500 ARG B 105 -11.21 -49.83 REMARK 500 GLU B 107 139.32 -37.17 REMARK 500 ARG B 158 66.86 -109.15 REMARK 500 ILE B 163 -14.37 -47.03 REMARK 500 PHE B 187 77.49 -118.12 REMARK 500 PRO B 188 129.40 -37.89 REMARK 500 VAL B 195 57.64 -114.20 REMARK 500 GLU B 200 97.83 -55.56 REMARK 500 THR B 201 145.79 -170.18 REMARK 500 PRO B 263 -80.71 -47.82 REMARK 500 ALA B 328 -8.44 -57.97 REMARK 500 ASN B 386 -6.76 -56.58 REMARK 500 CYS B 435 80.27 -66.65 REMARK 500 ASP B 462 -169.66 -124.41 REMARK 500 ASN B 492 -91.53 -155.13 REMARK 500 ILE B 509 150.77 -47.73 REMARK 500 GLU B 513 156.70 -43.19 REMARK 500 ASP B 530 10.22 -67.55 REMARK 500 ARG B 568 24.17 -72.72 REMARK 500 GLU B 593 88.33 -160.03 REMARK 500 ALA B 627 0.72 -61.05 REMARK 500 REMARK 500 THIS ENTRY HAS 76 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R79 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R79 B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C8E C 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R79 C 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GSZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A SQUALENE CYCLASE IN COMPLEX WITH THE REMARK 900 POTENTIAL ANTICHOLESTEREMIC DRUG RO48-8071 REMARK 900 RELATED ID: 1H35 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H36 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H37 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H39 RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H3A RELATED DB: PDB REMARK 900 STRUCTURES OF HUMAN OXIDOSQUALENE CYCLASE INHIBITORS BOUND TO A REMARK 900 HOMOLGOUS ENZYME REMARK 900 RELATED ID: 1H3B RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE REMARK 900 RELATED ID: 1SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE-CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS REMARK 900 RELATED ID: 2SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE FROM ALICYCLOBACILLUS ACIDOCALDARIUS REMARK 900 RELATED ID: 3SQC RELATED DB: PDB REMARK 900 SQUALENE-HOPENE CYCLASE DBREF 1H3C A 1 1 PDB 1H3C 1H3C 1 1 DBREF 1H3C A 2 631 UNP P33247 SQHC_ALIAC 1 630 DBREF 1H3C B 1 1 PDB 1H3C 1H3C 1 1 DBREF 1H3C B 2 631 UNP P33247 SQHC_ALIAC 1 630 DBREF 1H3C C 1 1 PDB 1H3C 1H3C 1 1 DBREF 1H3C C 2 631 UNP P33247 SQHC_ALIAC 1 630 SEQRES 1 A 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 A 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 A 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 A 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 A 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 A 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 A 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 A 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 A 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 A 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 A 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 A 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 A 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 A 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 A 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 A 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 A 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 A 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 A 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 A 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 A 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 A 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 A 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 A 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 A 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 A 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 A 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 A 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 A 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 A 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 A 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 A 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 A 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 A 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 A 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 A 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 A 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 A 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 A 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 A 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 A 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 A 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 A 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 A 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 A 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 A 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 A 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 A 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 A 631 LYS GLN ALA ILE GLU ARG ARG SEQRES 1 B 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 B 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 B 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 B 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 B 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 B 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 B 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 B 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 B 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 B 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 B 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 B 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 B 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 B 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 B 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 B 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 B 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 B 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 B 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 B 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 B 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 B 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 B 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 B 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 B 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 B 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 B 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 B 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 B 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 B 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 B 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 B 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 B 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 B 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 B 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 B 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 B 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 B 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 B 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 B 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 B 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 B 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 B 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 B 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 B 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 B 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 B 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 B 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 B 631 LYS GLN ALA ILE GLU ARG ARG SEQRES 1 C 631 MET ALA GLU GLN LEU VAL GLU ALA PRO ALA TYR ALA ARG SEQRES 2 C 631 THR LEU ASP ARG ALA VAL GLU TYR LEU LEU SER CYS GLN SEQRES 3 C 631 LYS ASP GLU GLY TYR TRP TRP GLY PRO LEU LEU SER ASN SEQRES 4 C 631 VAL THR MET GLU ALA GLU TYR VAL LEU LEU CYS HIS ILE SEQRES 5 C 631 LEU ASP ARG VAL ASP ARG ASP ARG MET GLU LYS ILE ARG SEQRES 6 C 631 ARG TYR LEU LEU HIS GLU GLN ARG GLU ASP GLY THR TRP SEQRES 7 C 631 ALA LEU TYR PRO GLY GLY PRO PRO ASP LEU ASP THR THR SEQRES 8 C 631 ILE GLU ALA TYR VAL ALA LEU LYS TYR ILE GLY MET SER SEQRES 9 C 631 ARG ASP GLU GLU PRO MET GLN LYS ALA LEU ARG PHE ILE SEQRES 10 C 631 GLN SER GLN GLY GLY ILE GLU SER SER ARG VAL PHE THR SEQRES 11 C 631 ARG MET TRP LEU ALA LEU VAL GLY GLU TYR PRO TRP GLU SEQRES 12 C 631 LYS VAL PRO MET VAL PRO PRO GLU ILE MET PHE LEU GLY SEQRES 13 C 631 LYS ARG MET PRO LEU ASN ILE TYR GLU PHE GLY SER TRP SEQRES 14 C 631 ALA ARG ALA THR VAL VAL ALA LEU SER ILE VAL MET SER SEQRES 15 C 631 ARG GLN PRO VAL PHE PRO LEU PRO GLU ARG ALA ARG VAL SEQRES 16 C 631 PRO GLU LEU TYR GLU THR ASP VAL PRO PRO ARG ARG ARG SEQRES 17 C 631 GLY ALA LYS GLY GLY GLY GLY TRP ILE PHE ASP ALA LEU SEQRES 18 C 631 ASP ARG ALA LEU HIS GLY TYR GLN LYS LEU SER VAL HIS SEQRES 19 C 631 PRO PHE ARG ARG ALA ALA GLU ILE ARG ALA LEU ASP TRP SEQRES 20 C 631 LEU LEU GLU ARG GLN ALA GLY ASP GLY SER TRP GLY GLY SEQRES 21 C 631 ILE GLN PRO PRO TRP PHE TYR ALA LEU ILE ALA LEU LYS SEQRES 22 C 631 ILE LEU ASP MET THR GLN HIS PRO ALA PHE ILE LYS GLY SEQRES 23 C 631 TRP GLU GLY LEU GLU LEU TYR GLY VAL GLU LEU ASP TYR SEQRES 24 C 631 GLY GLY TRP MET PHE GLN ALA SER ILE SER PRO VAL TRP SEQRES 25 C 631 ASP THR GLY LEU ALA VAL LEU ALA LEU ARG ALA ALA GLY SEQRES 26 C 631 LEU PRO ALA ASP HIS ASP ARG LEU VAL LYS ALA GLY GLU SEQRES 27 C 631 TRP LEU LEU ASP ARG GLN ILE THR VAL PRO GLY ASP TRP SEQRES 28 C 631 ALA VAL LYS ARG PRO ASN LEU LYS PRO GLY GLY PHE ALA SEQRES 29 C 631 PHE GLN PHE ASP ASN VAL TYR TYR PRO ASP VAL ASP ASP SEQRES 30 C 631 THR ALA VAL VAL VAL TRP ALA LEU ASN THR LEU ARG LEU SEQRES 31 C 631 PRO ASP GLU ARG ARG ARG ARG ASP ALA MET THR LYS GLY SEQRES 32 C 631 PHE ARG TRP ILE VAL GLY MET GLN SER SER ASN GLY GLY SEQRES 33 C 631 TRP GLY ALA TYR ASP VAL ASP ASN THR SER ASP LEU PRO SEQRES 34 C 631 ASN HIS ILE PRO PHE CYS ASP PHE GLY GLU VAL THR ASP SEQRES 35 C 631 PRO PRO SER GLU ASP VAL THR ALA HIS VAL LEU GLU CYS SEQRES 36 C 631 PHE GLY SER PHE GLY TYR ASP ASP ALA TRP LYS VAL ILE SEQRES 37 C 631 ARG ARG ALA VAL GLU TYR LEU LYS ARG GLU GLN LYS PRO SEQRES 38 C 631 ASP GLY SER TRP PHE GLY ARG TRP GLY VAL ASN TYR LEU SEQRES 39 C 631 TYR GLY THR GLY ALA VAL VAL SER ALA LEU LYS ALA VAL SEQRES 40 C 631 GLY ILE ASP THR ARG GLU PRO TYR ILE GLN LYS ALA LEU SEQRES 41 C 631 ASP TRP VAL GLU GLN HIS GLN ASN PRO ASP GLY GLY TRP SEQRES 42 C 631 GLY GLU ASP CYS ARG SER TYR GLU ASP PRO ALA TYR ALA SEQRES 43 C 631 GLY LYS GLY ALA SER THR PRO SER GLN THR ALA TRP ALA SEQRES 44 C 631 LEU MET ALA LEU ILE ALA GLY GLY ARG ALA GLU SER GLU SEQRES 45 C 631 ALA ALA ARG ARG GLY VAL GLN TYR LEU VAL GLU THR GLN SEQRES 46 C 631 ARG PRO ASP GLY GLY TRP ASP GLU PRO TYR TYR THR GLY SEQRES 47 C 631 THR GLY PHE PRO GLY ASP PHE TYR LEU GLY TYR THR MET SEQRES 48 C 631 TYR ARG HIS VAL PHE PRO THR LEU ALA LEU GLY ARG TYR SEQRES 49 C 631 LYS GLN ALA ILE GLU ARG ARG HET C8E A 700 21 HET R79 A 800 28 HET C8E B 700 21 HET R79 B 800 28 HET C8E C 700 21 HET R79 C 800 28 HETNAM C8E (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE HETNAM R79 N-(6-{[3-(4-BROMOPHENYL)-1,2-BENZISOTHIAZOL-6- HETNAM 2 R79 YL]OXY}HEXYL)-N-METHYLPROP-2-EN-1-AMINE FORMUL 4 C8E 3(C16 H34 O5) FORMUL 5 R79 3(C23 H27 BR N2 O S) FORMUL 10 HOH *191(H2 O) HELIX 1 1 TYR A 11 GLN A 26 1 16 HELIX 2 2 VAL A 40 LEU A 53 1 14 HELIX 3 3 ASP A 57 GLN A 72 1 16 HELIX 4 4 ASP A 87 GLY A 102 1 16 HELIX 5 5 GLU A 107 SER A 119 1 13 HELIX 6 6 GLN A 120 SER A 126 5 7 HELIX 7 7 ARG A 127 VAL A 137 1 11 HELIX 8 8 PRO A 141 VAL A 145 5 5 HELIX 9 9 PRO A 149 LEU A 155 5 7 HELIX 10 10 ASN A 162 PHE A 166 5 5 HELIX 11 11 GLY A 167 GLN A 184 1 18 HELIX 12 12 PRO A 190 ARG A 194 5 5 HELIX 13 13 VAL A 195 TYR A 199 5 5 HELIX 14 14 GLY A 215 GLN A 229 1 15 HELIX 15 15 PHE A 236 GLN A 252 1 17 HELIX 16 16 ILE A 261 LEU A 275 1 15 HELIX 17 17 HIS A 280 LEU A 290 1 11 HELIX 18 18 SER A 309 GLY A 325 1 17 HELIX 19 19 HIS A 330 GLN A 344 1 15 HELIX 20 20 GLY A 349 LYS A 354 5 6 HELIX 21 21 ASP A 374 THR A 387 1 14 HELIX 22 22 ASP A 392 GLY A 409 1 18 HELIX 23 23 LEU A 428 ILE A 432 5 5 HELIX 24 24 SER A 445 GLY A 460 1 16 HELIX 25 25 TRP A 465 GLN A 479 1 15 HELIX 26 26 ASN A 492 VAL A 507 1 16 HELIX 27 27 GLU A 513 GLN A 525 1 13 HELIX 28 28 ASP A 536 GLU A 541 5 6 HELIX 29 29 ASP A 542 ALA A 546 5 5 HELIX 30 30 THR A 552 GLY A 566 1 15 HELIX 31 31 SER A 571 GLN A 585 1 15 HELIX 32 32 MET A 611 LYS A 625 1 15 HELIX 33 33 TYR B 11 GLN B 26 1 16 HELIX 34 34 VAL B 40 LEU B 53 1 14 HELIX 35 35 ASP B 57 GLN B 72 1 16 HELIX 36 36 ASP B 87 GLY B 102 1 16 HELIX 37 37 GLU B 107 SER B 119 1 13 HELIX 38 38 GLN B 120 SER B 126 5 7 HELIX 39 39 ARG B 127 VAL B 137 1 11 HELIX 40 40 PRO B 141 VAL B 145 5 5 HELIX 41 41 PRO B 149 LEU B 155 5 7 HELIX 42 42 ASN B 162 PHE B 166 5 5 HELIX 43 43 GLY B 167 GLN B 184 1 18 HELIX 44 44 PRO B 190 ARG B 194 5 5 HELIX 45 45 VAL B 195 TYR B 199 5 5 HELIX 46 46 GLY B 215 GLN B 229 1 15 HELIX 47 47 PHE B 236 GLN B 252 1 17 HELIX 48 48 ILE B 261 LEU B 275 1 15 HELIX 49 49 HIS B 280 LEU B 290 1 11 HELIX 50 50 SER B 309 GLY B 325 1 17 HELIX 51 51 HIS B 330 GLN B 344 1 15 HELIX 52 52 GLY B 349 LYS B 354 5 6 HELIX 53 53 ASP B 374 ASN B 386 1 13 HELIX 54 54 ASP B 392 GLY B 409 1 18 HELIX 55 55 LEU B 428 ILE B 432 5 5 HELIX 56 56 SER B 445 PHE B 459 1 15 HELIX 57 57 TRP B 465 GLN B 479 1 15 HELIX 58 58 ASN B 492 VAL B 507 1 16 HELIX 59 59 GLU B 513 HIS B 526 1 14 HELIX 60 60 ASP B 536 GLU B 541 5 6 HELIX 61 61 ASP B 542 ALA B 546 5 5 HELIX 62 62 THR B 552 GLY B 566 1 15 HELIX 63 63 SER B 571 GLN B 585 1 15 HELIX 64 64 MET B 611 LYS B 625 1 15 HELIX 65 65 TYR C 11 GLN C 26 1 16 HELIX 66 66 VAL C 40 LEU C 53 1 14 HELIX 67 67 ASP C 57 GLN C 72 1 16 HELIX 68 68 ASP C 87 GLY C 102 1 16 HELIX 69 69 GLU C 107 SER C 119 1 13 HELIX 70 70 GLN C 120 SER C 126 5 7 HELIX 71 71 ARG C 127 VAL C 137 1 11 HELIX 72 72 PRO C 141 VAL C 145 5 5 HELIX 73 73 PRO C 149 LEU C 155 5 7 HELIX 74 74 ASN C 162 PHE C 166 5 5 HELIX 75 75 GLY C 167 GLN C 184 1 18 HELIX 76 76 PRO C 190 ARG C 194 5 5 HELIX 77 77 VAL C 195 TYR C 199 5 5 HELIX 78 78 GLY C 215 LEU C 231 1 17 HELIX 79 79 PHE C 236 GLN C 252 1 17 HELIX 80 80 ILE C 261 LEU C 275 1 15 HELIX 81 81 HIS C 280 GLY C 289 1 10 HELIX 82 82 LEU C 290 LEU C 292 5 3 HELIX 83 83 SER C 309 GLY C 325 1 17 HELIX 84 84 HIS C 330 GLN C 344 1 15 HELIX 85 85 GLY C 349 LYS C 354 5 6 HELIX 86 86 ASP C 374 ASN C 386 1 13 HELIX 87 87 ASP C 392 MET C 410 1 19 HELIX 88 88 LEU C 428 ILE C 432 5 5 HELIX 89 89 SER C 445 GLY C 460 1 16 HELIX 90 90 TRP C 465 GLN C 479 1 15 HELIX 91 91 ASN C 492 VAL C 507 1 16 HELIX 92 92 GLU C 513 GLN C 525 1 13 HELIX 93 93 ASP C 536 GLU C 541 5 6 HELIX 94 94 ASP C 542 ALA C 546 5 5 HELIX 95 95 THR C 552 GLY C 566 1 15 HELIX 96 96 SER C 571 GLN C 585 1 15 HELIX 97 97 MET C 611 LYS C 625 1 15 SHEET 1 AA 3 LEU A 36 LEU A 37 0 SHEET 2 AA 3 PHE A 605 TYR A 609 -1 O GLY A 608 N LEU A 37 SHEET 3 AA 3 GLY A 598 PHE A 601 -1 O GLY A 598 N LEU A 607 SHEET 1 AB 2 GLY A 294 GLU A 296 0 SHEET 2 AB 2 TRP A 302 PHE A 304 -1 O MET A 303 N VAL A 295 SHEET 1 BA 3 LEU B 36 LEU B 37 0 SHEET 2 BA 3 PHE B 605 TYR B 609 -1 O GLY B 608 N LEU B 37 SHEET 3 BA 3 GLY B 598 PHE B 601 -1 O GLY B 598 N LEU B 607 SHEET 1 BB 2 GLY B 294 GLU B 296 0 SHEET 2 BB 2 TRP B 302 PHE B 304 -1 O MET B 303 N VAL B 295 SHEET 1 CA 3 LEU C 36 LEU C 37 0 SHEET 2 CA 3 PHE C 605 TYR C 609 -1 O GLY C 608 N LEU C 37 SHEET 3 CA 3 GLY C 598 PHE C 601 -1 O GLY C 598 N LEU C 607 SHEET 1 CB 2 GLY C 294 GLU C 296 0 SHEET 2 CB 2 TRP C 302 PHE C 304 -1 O MET C 303 N VAL C 295 CISPEP 1 VAL A 491 ASN A 492 0 -0.18 CISPEP 2 VAL B 491 ASN B 492 0 -0.09 CISPEP 3 VAL C 491 ASN C 492 0 -0.13 SITE 1 AC1 8 GLU A 250 ARG A 251 PRO A 348 ASP A 350 SITE 2 AC1 8 VAL A 353 TYR A 371 ARG B 238 ILE B 242 SITE 1 AC2 10 THR A 173 PRO A 263 ASP A 374 ASP A 376 SITE 2 AC2 10 PHE A 437 TRP A 489 PHE A 601 PHE A 605 SITE 3 AC2 10 HOH A2028 HOH A2051 SITE 1 AC3 6 ARG A 183 ARG A 238 ILE A 242 GLY B 349 SITE 2 AC3 6 VAL B 353 TYR B 371 SITE 1 AC4 12 ALA B 170 THR B 173 PRO B 263 ASP B 374 SITE 2 AC4 12 ASP B 376 ASP B 377 TYR B 420 TRP B 489 SITE 3 AC4 12 PHE B 601 PHE B 605 LEU B 607 HOH B2031 SITE 1 AC5 6 ARG C 238 GLU C 241 ILE C 242 ARG C 251 SITE 2 AC5 6 GLY C 349 TYR C 371 SITE 1 AC6 8 THR C 173 PRO C 263 ASP C 374 PHE C 437 SITE 2 AC6 8 TRP C 489 PHE C 601 PHE C 605 LEU C 607 CRYST1 140.755 140.755 244.307 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007104 0.004102 0.000000 0.00000 SCALE2 0.000000 0.008204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004093 0.00000 MTRIX1 1 -0.483920 -0.875100 -0.003550 140.94014 1 MTRIX2 1 0.875110 -0.483930 -0.000510 -5.22846 1 MTRIX3 1 -0.001270 -0.003350 0.999990 1.37213 1 MTRIX1 2 -0.529430 0.848260 -0.012540 77.78583 1 MTRIX2 2 -0.848290 -0.529510 -0.003850 121.33225 1 MTRIX3 2 -0.009910 0.008600 0.999910 0.28685 1